Werewolf Therapeutics Inc (HOWL) Stock Analysis

Werewolf Therapeutics Inc (HOWL) is a publicly traded company in the HEALTHCARE sector. It trades at $0.43, carries a market capitalization of $21.87M. This page summarizes the public market data, fundamentals, and frequently asked questions for HOWL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.43
• Market Cap: $21.87M
• EPS: $-1.21
• 52-Week High: $2.38
• 52-Week Low: $0.40

Market Sentiment

Werewolf Therapeutics Inc currently has a Bearish sentiment score of -0.15.

About Werewolf Therapeutics Inc

Werewolf Therapeutics, Inc. (HOWL) is an innovative biopharmaceutical company focused on developing next-generation immune-based therapies for cancer treatment. Headquartered in Cambridge, Massachusetts, the company utilizes its proprietary platform to engineer novel therapeutics that enhance the body’s immune response against tumors. With a robust pipeline of product candidates targeting a range of oncology indications, Werewolf Therapeutics is well-positioned to advance its mission of impro...

GNG Research Analysis

GNG Research scores Werewolf Therapeutics Inc (HOWL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HOWL.

Frequently Asked Questions

Does HOWL pay dividends?

Werewolf Therapeutics Inc (HOWL) does not currently pay a regular dividend.

What is HOWL's market cap?

Werewolf Therapeutics Inc (HOWL) has a market capitalization of $21.87M with a current stock price of $0.43.